Schmidmaier et al. [29] observed that while the in vivo progression of the tumor in a myeloma model was related to high rate of proliferation of LFA-1 positive tumor cells, they only detected a slight variation, although not significant, in the levels of several cyclins [30]. This evidence concerns the gene ITGB2 and plasma cell myeloma.